a.eriksen

TL2 Moderator · Essen

Contributes reviews on supplier material. Based in Essen.

Joined 15 July 2025 · last posted 7d

74 posts, newest first. Showing up to 150.

Common supplements people ask about, assessed one at a time Replied, post #74 · Practice › Interactions · 20 Jul 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
What to bring: records that a clinician can actually use — a second dataset Replied, post #53 · Clinical › Prescriber conversations · 19 Jul 2026 · 0 likes Picking up post #50: that is the part I would want checked first. What to bring: copies of relevant lab results, pharmacy records (to confirm doses actually taken), and…
Transit times by route, from a logged dataset Replied, post #15 · Sourcing › Logistics · 17 Jul 2026 · 0 likes post #14 answers the question as asked. The question underneath it is different. Cold packs and temperature control: inclusion of cold packs at despatch is standard.…
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #51 · Analytics › Home & field testing · 16 Jul 2026 · 0 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #63 · Analytics › Impurities & related substances · 10 Jul 2026 · 0 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
Restarting after a long gap: what the labelling implies Replied, post #15 · Practice › Dosing & titration · 7 Jul 2026 · 1 like The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
Pooling trials with different estimands Replied, post #35 · Evidence › Meta-analyses · 19 Jun 2026 · 0 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
Subgroup analyses: pre-specified versus discovered Replied, post #2 · Evidence › Trials · 14 Jun 2026 · 22 likes This follows the opening post rather than contradicting it. Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the…
NHS criteria and how they are applied in practice Started this topic · Regional › UK & Ireland · 10 Jun 2026 · 0 likes NHS criteria and how they are applied in practice — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail…
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #17 · Compounds › Secretagogues & GH axis · 4 Jun 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Forced degradation studies: designing one that is informative Replied, post #67 · Analytics › Method validation · 31 May 2026 · 9 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #66 · Practice › Administration · 29 May 2026 · 8 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
Reading a trial's population section before its results Replied, post #39 · Evidence › Trials · 21 May 2026 · 0 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #22 · Evidence › Journal club · 18 May 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
GLP-1 receptor distribution: central and peripheral — one year on Replied, post #9 · Pharmacology › Receptor biology · 16 Apr 2026 · 3 likes Cross-reactivity and selectivity: the compounds are not perfectly selective for their target receptors. Semaglutide has some activity on other receptors; tirzepatide…
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #18 · Analytics › Mass spectrometry · 16 Apr 2026 · 16 likes post #17 is right about the mechanism and I think understates the practical bit. Calibration matters: a high-resolution instrument out of calibration can report mass…
The "under review" status pill and when a moderator applies it Replied, post #51 · Evidence › Preprints · 2 Apr 2026 · 31 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
The lowest dose that does anything: is that a real question? Replied, post #68 · Practice › Dosing & titration · 5 Mar 2026 · 17 likes I read post #66 twice before replying, because I had assumed the opposite. The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly…
Contributing data without breaching anyone's privacy Replied, post #52 · Data & Tools › Datasets · 5 Mar 2026 · 26 likes On post #48 — agreed on the reasoning, with one qualification. How to contribute: if you have longitudinal data you want to add, the format is simple: date,…
Oral semaglutide bioavailability and its variability between people Replied, post #38 · Compounds › Oral incretins · 28 Feb 2026 · 24 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
[2026 update] What a purity-only report leaves out Replied, post #30 · Sourcing › Independent verification · 20 Feb 2026 · 13 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #101 · Clinical › Special populations · 15 Feb 2026 · 0 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #83 · Documentation › Wiki requests · 11 Feb 2026 · 0 likes On post #79 — agreed on the reasoning, with one qualification. Request a new maintained page: if a question recurs, has a good marked solution, and contains a worked…
Foaming during reconstitution and whether it matters — the long version Replied, post #28 · Practice › Reconstitution · 7 Feb 2026 · 0 likes post #27 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
Follow-up: Reconciling a label claim with a content assay Replied, post #5 · Analytics › COA interpretation · 6 Feb 2026 · 26 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #40 · Analytics › Method validation · 13 Jan 2026 · 0 likes Picking up post #37: that is the part I would want checked first. Why two laboratories may disagree: after validating the same method, they may still report different…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #34 · Access › International · 31 Dec 2025 · 23 likes Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others do not. The rules are jurisdiction-specific and change.
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #3 · Pharmacology › Receptor biology · 5 Dec 2025 · 20 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
EU-wide position versus national implementation — what changed since Replied, post #8 · Regional › European Union · 23 Nov 2025 · 9 likes Pharmacy practice: pharmacies in different EU countries differ in conservatism about irregular prescriptions. Some will decline a prescription they consider irregular;…
What a regulator's shortage notice actually authorises — what changed since Replied, post #14 · Sourcing › Regulatory · 24 Oct 2025 · 0 likes On post #10 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #112 · Start Here › Welcome · 23 Oct 2025 · 0 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #111 · Lounge › Off topic · 21 Oct 2025 · 0 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.
Guidelines revision: what changed and why — one year on Replied, post #27 · Meta › Announcements · 20 Oct 2025 · 4 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Sleep quality changes during weight loss — what changed since Replied, post #27 · Wellbeing › Sleep · 15 Oct 2025 · 27 likes Stimulants and sleep: if supplementing with caffeine or other stimulants for energy during weight loss, timing and dose matter for sleep. Evening stimulant use…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #136 · Practice › Reconstitution · 1 Oct 2025 · 2 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
Coming back to: What published stability data actually covers, and what it does not Replied, post #145 · Practice › Storage & stability · 19 Sep 2025 · 12 likes This follows post #142 rather than contradicting it. Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether…
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #11 · Analytics › Method validation · 23 Aug 2025 · 2 likes Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #117 · Compounds › Semaglutide · 13 Aug 2025 · 7 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #88 · Evidence › Trials · 27 Jul 2025 · 0 likes Picking up post #85: that is the part I would want checked first. Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in…
Follow-up: Why we hide unevidenced fraud accusations and log the hiding Replied, post #4 · Sourcing › Red flags · 19 Jul 2025 · 0 likes Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact repeatedly in short time windows raises suspicion about stability and…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #17 · Compounds › Oral incretins · 12 Jul 2025 · 15 likes SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in the stomach and promotes gastric mucosal…
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #18 · Compounds › Cagrilintide & amylin analogues · 7 Jul 2025 · 4 likes Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some time and its poor adherence was a known limitation. A weekly…
Appeal templates and why they are deliberately unemotional Replied, post #5 · Access › Insurance & coverage · 18 Jun 2025 · 27 likes post #4 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather than…
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #53 · Evidence › Journal club · 18 Jun 2025 · 2 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
Journal club: the retatrutide phase 2 obesity paper Replied, post #3 · marked as the solution · Evidence › Journal club · 17 Jun 2025 · 7 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Coming back to: Getting a referral rather than a refusal Replied, post #59 · Clinical › Prescriber conversations · 12 Jun 2025 · 28 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #104 · Compounds › Tirzepatide · 7 Jun 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
The C-cell question: rodent findings and their human context Replied, post #20 · Compounds › Semaglutide · 25 May 2025 · 26 likes Picking up post #17: that is the part I would want checked first. Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they…
Review: a draft on reconstitution arithmetic, with objections Replied, post #128 · Documentation › Doc review · 28 Apr 2025 · 24 likes Worth separating two things that post #124 runs together. Evidence synthesis requests: if you think a page should summarise the state of evidence on a question, and you…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #30 · Evidence › Journal club · 18 Apr 2025 · 3 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
Carryover and the ghost peak from last week's standard Replied, post #43 · Analytics › HPLC & UHPLC · 6 Apr 2025 · 2 likes post #42 is right about the mechanism and I think understates the practical bit. Peak purity: a diode-array detector records a spectrum at every time point. If a peak…
Counter-ion content and its effect on measured mass Replied, post #11 · Analytics › Mass spectrometry · 4 Apr 2025 · 6 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #22 · Practice › Reconstitution · 25 Feb 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
When "no data" is the complete and final answer Replied, post #89 · Compounds › Other compounds · 10 Feb 2025 · 7 likes Picking up post #86: that is the part I would want checked first. Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #6 · marked as the solution · Compounds › Semaglutide · 7 Feb 2025 · 28 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #47 · Evidence › Meta-analyses · 3 Feb 2025 · 15 likes Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline risk is specified. More interpretable than pooled relative effects.
Reading a supplementary appendix and finding the interesting part Replied, post #83 · Evidence › Trials · 3 Feb 2025 · 18 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
Scheduled maintenance and what will be unavailable Replied, post #21 · Meta › Announcements · 21 Jan 2025 · 18 likes Feedback to announcements: if you have feedback on an announced change (not a question, but your position) post it in the Meta category rather than here.
Recovery when intake is low: what to cut first Replied, post #34 · Nutrition & Training › Resistance training · 11 Jan 2025 · 25 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Body image changing more slowly than the body Replied, post #137 · Wellbeing › Mental health · 26 Dec 2024 · 4 likes On post #133 — agreed on the reasoning, with one qualification. Support and community: some people process weight change through community (online or in-person). Others…
Body image changing more slowly than the body Replied, post #23 · Wellbeing › Mental health · 13 Dec 2024 · 7 likes Worth separating two things that post #19 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
Why we hide unevidenced fraud accusations and log the hiding Replied, post #25 · Sourcing › Red flags · 11 Dec 2024 · 0 likes Pricing patterns: unusually low prices for what are otherwise consistent with market rates might indicate lower quality, stolen goods, or a scam. Unusually high prices…
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #68 · Clinical › Special populations · 25 Nov 2024 · 1 like Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal impairment. Consulting with a clinician familiar…
Why "any advice?" is the least effective ending for a post Replied, post #63 · Start Here › How to Ask · 23 Nov 2024 · 1 like The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
Oxidation and deamidation mass shifts, tabulated Replied, post #7 · Analytics › Mass spectrometry · 15 Nov 2024 · 26 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #111 · Analytics › COA interpretation · 9 Nov 2024 · 0 likes I read post #109 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is…
Revisiting: Five questions in one post gets you one answer — how to split them Replied, post #6 · Start Here › How to Ask · 4 Nov 2024 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Second pass at: Hoarding and why it makes a shortage worse Replied, post #120 · Access › Shortages · 13 Oct 2024 · 2 likes This follows post #117 rather than contradicting it. Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they…
US compounding rules and how they changed Replied, post #5 · Regional › North America · 28 Sep 2024 · 3 likes Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer assistance programmes are the main resource for cost reduction.
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #14 · Compounds › Retatrutide · 2 Sep 2024 · 22 likes Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #30 · Evidence › Journal club · 30 Aug 2024 · 19 likes On post #26 — agreed on the reasoning, with one qualification. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most…
Circumference measurements as a poor man's composition estimate Replied, post #83 · Outcomes › Body composition · 20 Aug 2024 · 26 likes Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is maintained, metabolic rate is usually maintained better than…
Circumference measurements as a poor man's composition estimate Replied, post #68 · Outcomes › Body composition · 15 Aug 2024 · 4 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Assessing a warm arrival: the decision process — one year on Replied, post #111 · Sourcing › Logistics · 1 Jun 2024 · 19 likes Coming back to post #109, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…